Fact CheckerSign in

NCT04852354Recruiting

Tissue Collection for Drug Screening and Bioanalysis

Source: ClinicalTrials.gov · Last updated 17 Dec 2025

Brief summary (registry, in English)

The purpose of this study is to improve upon the knowledge currently available about central nervous system (CNS) tumors. We will study the different characteristics of these tumors using tissue samples collected during surgery and post-autopsy. The aim is to create tumor cell lines and models to test how they respond to different drugs. This research will help improve treatment options and identify new targets for therapy.

Status (registry)
Recruiting
Study type
Observational
Enrollment
500 (estimated)
First submitted
10 Apr 2021
Start date
22 Jul 2020
Primary completion date
22 Jul 2029
Lead sponsor
Weill Medical College of Cornell University
NCT number
NCT04852354

What you commit to

  • Study type: Observational
  • Planned participants: 500
  • From 22 Jul 2020 to the primary completion date, 22 Jul 2029
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

  • Subject has presented with a suspected/confirmed neoplastic CNS lesion and is undergoing a neurosurgical procedure in which CNS tissue and/or tumors associated with this tissue will be removed.
  • There must be tissue available in excess of that required by neuropathology for diagnostic purposes.
  • Subject of all ages included.
  • Subjects who are pregnant can be included.
  • Subjects who are neonates (0-4 weeks) can be included.
  • Subject is between 4 weeks and 21 years of age and is undergoing a neurosurgical procedure at WCMC.
  • Subject does not have a CNS tumor diagnosis.
  • Subject should not be pregnant at the time of enrollment.
  • Subject of all ages included
  • Subject has been diagnosed with a neoplastic CNS lesion at the time of passing.
  • Subjects who are pregnant can be included.
  • Subjects who are neonates (0-4 weeks) can be included.
  • Subject is the biological parent of a patient undergoing/ who underwent a neurosurgical procedure in which CNS tissue and/or tumors associated with this tissue will be/ was removed.
  • Subject is the biological parent of patient enrolled in cohort 1.
  • Subject is not pregnant at the time of enrollment.

Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Weill Cornell Medicine
Coordinator of this site? Confirm its status
New YorkUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.